Rang	Name	Position
1	Dr. Anish Bhatnagar M.D.	Chairman, President & CEO
2	Mr. James H. MacKaness	Executive Officer
3	Ms. Meredith Manning M.B.A.	Chief Commercial Officer
4	Mr. Kevin Norrett M.B.A., M.S.	Chief Business Officer
5	Dr. Manher A. Joshi M.D.	Chief Development Officer
6	Ms. Jennifer Fulk	Chief Financial Officer
7	Mr. Jesse Schumaker	General Counsel
8	Ms. Lauren Budesheim	Senior Vice President of People
9	Ms. Kristen Yen M.S.	Senior Vice President of Global Clinical Operations and Patient Advocacy
10	Dr. Neil M. Cowen M.B.A., Ph.D.	Senior Vice President of New Product Planning

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	HHG PLC	13,62%	0,38 Mrd. USD
2	FMR Inc	11,11%	0,31 Mrd. USD
3	Wellington Management Company LLP	8,49%	0,24 Mrd. USD
4	BlackRock Inc	7,18%	0,20 Mrd. USD
5	Vanguard Group Inc	5,87%	0,16 Mrd. USD
6	State Street Corp	5,14%	0,14 Mrd. USD
7	venBio Select Advisor LLC	4,41%	0,12 Mrd. USD
8	Vanguard Capital Management, LLC	4,13%	0,11 Mrd. USD
9	Nantahala Capital Management, LLC	3,35%	0,09 Mrd. USD
10	Polar Capital Holdings PLC	3,26%	0,09 Mrd. USD
11	Khrom Capital Management, LLC	2,90%	0,08 Mrd. USD
12	Geode Capital Management, LLC	2,37%	0,07 Mrd. USD
13	Woodline Partners LP	2,13%	0,06 Mrd. USD
14	Deep Track Capital, LP	2,07%	0,06 Mrd. USD
15	T. Rowe Price Associates, Inc.	1,97%	0,05 Mrd. USD
16	BRAIDWELL LP	1,84%	0,05 Mrd. USD
17	Readystate Asset Management LP	1,68%	0,05 Mrd. USD
18	Franklin Resources Inc	1,60%	0,04 Mrd. USD
19	Vestal Point Capital LP	1,40%	0,04 Mrd. USD
20	COMMODORE CAPITAL LP	1,25%	0,04 Mrd. USD